Devices & Diagnostics

10 heart-focused apps & devices are crowdfunding for American Heart Association’s open innovation challenge

Nearly a quarter of patients who are hospitalized for heart failure are readmitted to the hospital within 30 days. Health Recovery Solutions developed an iPad- based program to keep patients on track and help hospitals identify which patients are at risk for being readmitted. In the seven hospitals that currently use the program, patients are […]

Nearly a quarter of patients who are hospitalized for heart failure are readmitted to the hospital within 30 days. Health Recovery Solutions developed an iPad- based program to keep patients on track and help hospitals identify which patients are at risk for being readmitted.

In the seven hospitals that currently use the program, patients are given a tablet before being discharged that’s loaded with the program. It gives them instructions to perform and track key actions like taking their medications, weighing themselves and staying active. Their data is sent to the cloud, where predictive analytics and algorithms determine if a care team should be alerted about a patient whose condition is deteriorating.

The American Heart Association chose Health Recovery Solutions’ technology as one of 10 finalists for its first Open Innovation Challenge, which was launched to find innovative tools that would help its efforts to lower the risk of heart disease and stroke.

The 10 finalists are running 30-day campaigns on the medical crowdfunding site Medstartr, and three winners will be selected based on funds raised, number of social shares and a panel of expert judges. Those teams will be invited to the association’s Health Sciences Innovation Investment Forum in NYC in March to present to investors and healthcare leaders. The winners will receive $25,000 in grants.

Other interesting projects include two wearable sensors and a filter to remove toxins from donated blood before it’s transmitted to the patient. View all of the finalists, donate or vote here.